Deferred Tax Assets, Valuation Allowance of enGene Holdings Inc. from 31 Oct 2022 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: enGene Holdings Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Oct 2022 to 31 Oct 2025.
enGene Holdings Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Oct 2025 was $80,426,000, a 64% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

enGene Holdings Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$80,426,000	+$31,434,000	+64%	31 Oct 2025	10-K	22 Dec 2025	2025	FY
Q3 2024	$48,992,000	+$17,907,000	+58%	31 Oct 2024	10-K	22 Dec 2025	2025	FY
Q3 2023	$31,085,000	+$9,037,000	+41%	31 Oct 2023	10-K	19 Dec 2024	2024	FY
Q3 2022	$22,048,000			31 Oct 2022	10-K	29 Jan 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.